Magnesium Bone Density Randomized Trial: What the Evidence Says

Quick Answer

Magnesium Bone Density Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are randomized trial, so conclusions should be framed as evidence-aware guidance rather than medical advice.

Key Takeaways

• This page is generated only from sources stored in the Migaku evidence knowledge base.
• Current evidence mix: 1 randomized trial, 1 preclinical study.
• Claims should be interpreted with the source type, study design, population, and publication date in mind.
• This article is educational and does not replace care from a qualified clinician.

Evidence Map

What The Sources Report

• Postmenopausal osteoporosis is characterized by a diminished bone mineral density, bone microarchitecture changes and an increased fracture risk. [Pickering Marie-Eva (2026); evidence level 2]
• BPs may alleviate pain by several mechanisms: action on bone sensory pain fibers and ion channels, peripheral pain sensitization, increased transcription, central sensitization, nerve sprouting and epigenetic modulation. [Pickering Marie-Eva (2026); evidence level 2]
• However, due to the limited number of human studies investigating the effects of vitamin D supplementation on implant outcomes, the current evidence remains weak and preliminary. [Sodnom-Ish Buyanbileg (2026); evidence level 4]
• Despite the recent growing interest and research insights, there is limited evidence on how the deficiency or supplementation of other micronutrients (e.g., boron, selenium, copper, or iron) influences osseointegration or the long-term implant survival and success. [Sodnom-Ish Buyanbileg (2026); evidence level 4]

How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

Practical Interpretation

There is trial evidence in the current set, but population and intervention details still matter. For magnesium bone density randomized trial, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

References

• Pickering Marie-Eva (2026). Quantitative sensory testing of pain in osteoporosis: a pilot randomized clinical trial with magnesium supplementation. DOI: 10.1007/s40520-025-03317-9. PMCID: PMC12872772. PMID: 41566091. License: https://creativecommons.org/licenses/by-nc-nd/4.0/ http://creativecommons.org/licenses/by-nc-nd/4.0/ This article is .... https://pmc.ncbi.nlm.nih.gov/articles/PMC12872772/
• Sodnom-Ish Buyanbileg (2026). The effect of dietary factors and nutrients on osseointegration, dental implant success and survival: a scoping review. DOI: 10.1186/s40729-026-00680-8. PMCID: PMC13187093. PMID: 41936654. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13187093/

Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.